Mandibular and dental manifestations of Gaucher disease

Oral Diseases

Volumn 18, Issue 5, 2012, Pages 421-429

  Saranjam, H R ^a   Sidransky, E ^a   Levine, W Z ^a   Zimran, A ^b   Elstein, D ^b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Enzyme replacement therapy; Gaucher cells; Gaucher disease; Glucocerebroside; Mandible; Maxilla

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GLUCOSYLCERAMIDASE; PENICILLIN G; TRANEXAMIC ACID;

ALVEOLAR BONE; BIOPSY; BLEEDING TENDENCY; CELL INFILTRATION; CHEEK MUCOSA; COMORBIDITY; CORTICAL BONE; DAILY LIFE ACTIVITY; DEBRIDEMENT; DENTAL SURGERY; FOLLOW UP; GAUCHER DISEASE; HEALING; HIGH RISK PATIENT; HUMAN; INFECTION; JAW OSTEONECROSIS; LONG BONE; LONG TERM CARE; MANDIBLE; MAXILLA; MOLAR TOOTH; MONOTHERAPY; MOUTH HYGIENE; OSTEOPENIA; OSTEOPOROSIS; PHYSICIAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SALIVATION; SKIN PIGMENTATION; THROMBOCYTE TRANSFUSION; TOOTH DISEASE; TOOTH ERUPTION; TOOTH EXTRACTION; TOOTH RADIOGRAPHY; TRABECULAR BONE;

BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; DENTAL CARE FOR CHRONICALLY ILL; GAUCHER DISEASE; HUMANS; MANDIBULAR DISEASES; ORAL HEMORRHAGE; POSTOPERATIVE HEMORRHAGE; SURGICAL WOUND INFECTION; TOOTH ERUPTION;

EID: 84861995991     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01898.x     Document Type: Review

References (61)

1. Abrahamov A, Elstein D, Gross-Tsur V et al (1995). Gaucher's disease variant characterized by progressive calcification of heart valves and unique genotype. Lancet 346: 1000-1003.
2. Aker M, Zimran A, Abrahamov A, Horowitz M, Matzner Y (1993). Abnormal neutrophil chemotaxis in Gaucher disease. Br J Haematol 83: 187-191.
3. Barton NW, Brady RO, Dambrosia JM et al (1991). Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 324: 1464-1470.
4. Bender IB (1938). Dental observations in Gaucher's disease. J Dent Res 17: 359.
5. Bender IB (1959). Dental observations in Gaucher's disease; a twenty-year follow-up. Oral Surg Oral Med Oral Pathol 12: 546-561.
6. Bender IB, Bender AL (1996). Dental observations in Gaucher's disease: review of the literature and two case reports with 13- and 60-year follow-ups. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82: 650-659.
7. Beutler E, Nguyen NJ, Henneberger MW et al (1993). Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet 52: 85-91.
8. Bildman B, Martinez M Jr, Robinson LH (1972). Gaucher's disease discovered by mandibular biopsy: report of case. J Oral Surg 30: 510-512.
9. Brock G, Barker K, Butterworth CJ, Rogers S (2011). Practical considerations for treatment of patients taking bisphosphonate medications: an update. Dent Update 38: 313-324.
10. Browne WG (1977). Oral pigmentation and root resorption in Gaucher's disease. J Oral Surg 35: 153-155.
11. Carter LC, Fischman SL, Mann J et al (1998). The nature and extent of jaw involvement in Gaucher disease: observations in a series of 28 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85: 233-239.
12. Cox TM, Aerts JM, Belmatoug N et al (2008). Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis 31: 319-336.
13. Dayan B, Elstein D, Zimran A, Nesher G (2003). Decreased salivary output in patients with Gaucher disease. QJM 96: 53-56.
14. Dweck A, Abrahamov A, Hadas-Halpern I, Bdolach-Avram T, Zimran A, Elstein D (2002). Type I Gaucher disease in children with and without enzyme therapy. Pediatr Hematol Oncol 19: 389-397.
15. Elstein D, Itzchaki M, Mankin HJ (1997). Skeletal involvement in Gaucher's disease. Baillieres Clin Haematol 10: 793-816.
16. Elstein D, Rosenmann E, Reinus C, Paz J, Altarescu G, Zimran A (2003). Amyloidosis and gastric bleeding in a patient with Gaucher disease. J Clin Gastroenterol 37: 234-237.
17. Fischman SL, Elstein D, Sgan-Cohen H, Mann J, Zimran A (2003). Dental profile of patients with Gaucher disease. BMC Oral Health 23: 3-4.
18. Germain DP (2004). Gaucher's disease: a paradigm for interventional genetics. Clin Genet 65: 77-86.
19. Gillis S, Hyam E, Abrahamov A, Elstein D, Zimran A (1999). Platelet function abnormalities in Gaucher disease patients. Am J Hematol 61: 103-106.
20. Givol N, Goldstein G, Peleg O et al (2012). Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease. Haemophilia 18: 117-121. doi:.
21. Goker-Alpan O (2011). Therapeutic approaches to bone pathology in Gaucher disease: past, present and future. Mol Gen Metab 104: 438-447. ISSN 1096-7192.
22. Grabowski GA, Barton NM, Pastores G et al (1995). Enzyme therapy in Gaucher disease type 1: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Int Med 122: 33-39.
23. Hadas-Halpern I, Deeb M, Abrahamov A, Zimran A, Elstein D (2010). Gaucher disease: spectrum of sonographic findings in the liver. J Ultrasound Med 29: 727-733.
24. Hall MB, Brown RW, Baughman RA (1985). Gaucher's disease affecting the mandible. J Oral Maxillofac Surg 43: 210-213.
25. Heasman PA (1991). Mandibular lesions in Gaucher disease. Oral Surg Oral Med Oral Pathol 72: 506.
26. Hollak CE, Levi M, Berends F, Aerts JM, van Oers MH (1997). Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol 96: 470-476.
27. Horwitz J, Hirsh I, Machtei EE (2007). Oral aspects of Gaucher's disease: a literature review and case report. J Periodontol 78: 783-788.
28. Itzchaki M, Lebel E, Dweck A et al (2004). Orthopedic considerations in Gaucher disease since the advent of enzyme replacement therapy. Acta Orthop Scand 75: 641-653.
29. Kaplan P, Mazur A, Manor O et al (1996). Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase. J Pediatr 129: 149-153.
30. Karabulut N, Ahmetoglu A, Ariyürek M, Erol C, Gürakan F (1997). Obliteration of maxillary and sphenoid sinuses in Gaucher's disease. Br J Radiol 70: 533-535.
31. Kerem E, Elstein D, Abrahamov A et al (1996). Pulmonary function abnormalities in type I Gaucher disease. Eur Respir J 9: 340-345.
32. Lebel E, Itzchaki M, Hadas-Halpern I, Zimran A, Elstein D (2001). Outcome of total hip arthroplasty in patients with Gaucher disease. J Arthroplasty 16: 7-12.
33. Lebel E, Ioscovich A, Itzchaki M, Zimran A, Elstein D (2011). Hip arthroplasty in patients with Gaucher disease. Blood Cells Mol Dis 46: 60-65.
34. Lustmann J, Ben-Yehuda D, Somer M, Ulmansky M (1991). Gaucher's disease affecting the mandible and maxilla. Report of a case. Int J Oral Maxillofac Surg 20: 7-8.
35. ]Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999). Prevalence of lysosomal storage disorders. JAMA 281: 249-254.
36. Michanowicz AE, Michanowicz JP, Stein GM (1967). Gaucher's disease: report of a case. Oral Surg Oral Med Oral Pathol 23: 36-42.
37. Mikosch P, Hughes D (2010). An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr 160: 609-624.
38. Mistry PK, Sirrs S, Chan A et al (2002). Pulmonary hypertension in type I Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy. Mol Genet Metab 77: 91-98.
39. Moch WS (1953). Gaucher's disease with mandibular bone lesions. Oral Surg Oral Med Oral Pathol 6: 1250-1254.
40. Pastores GM, Patel MJ, Firooznia H (2000). Bone and joint complications related to Gaucher disease. Curr Rheumatol Rep 2: 175-180.
41. Regenye GR, Huberman BA, Itkin AB (1992). Gaucher's disease: case report of mandibular trauma. Oral Surg Oral Med Oral Pathol 73: 23-26.
42. Renvert S, Berglund J, Persson RE, Persson GR (2011). Osteoporosis and periodontitis in older subjects participating in the Swedish National Survey on Aging and Care (SNAC-Blekinge). Acta Odontol Scand 69: 201-217.
43. Rudzki Z, Okoń K, Machaczka M, Rucińska M, Papla B, Skotnicki AB (2003). Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study. Eur J Haematol 70: 273-281.
44. Schubiner H, Letourneau M, Murray DL (1981). Pyogenic osteomyelitis versus pseudo-osteomyelitis in Gaucher's disease. Clin Pediatr 20: 667.
45. Sela J, Polliack A, Ulmansky M (1972). Involvement of the mandible in Gaucher's disease Report of a case with post-mortem findings. Br J Oral Surg 9: 246-250.
46. Shinoda H, Takeyama S, Suzuki K, Murakami S, Yamada S (2008). Pharmacological topics of bone metabolism: a novel bisphosphonate for the treatment of periodontitis. J Pharmacol Sci 106: 555-558.
47. Shira RB (1953). Manifestations of systemic disorders in the facial bones. J Oral Surg (Chic) 11: 286-307.
48. Shvidel L, Sigler E, Shtalrid M, Feldberg E, Berrebi A (2007). Parotid gland involvement, the presenting sign of high grade non-Hodgkin lymphoma in two patients with Gaucher disease and sicca syndrome. J Inherit Metab Dis 30: 825.
49. Sidransky E (2004). Gaucher disease: complexity in a "simple" disorder. Mol Genet Metab 83: 6-15.
50. Spiegel LH (1957). Gaucher's disease. Oral Surg Oral Med Oral Pathol 10: 158-166.
51. Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA (1985). Skeletal complications of Gaucher disease. Medicine (Baltimore) 64: 310-322.
52. Svennerholm L, Erikson A, Groth CG et al (1991). Norrbottnian type of Gaucher disease-Clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation. Dev Neurosci 13: 345-351.
53. Wactawski-Wende J, Grossi SG, Trevisan M et al (1996). The role of osteopenia in oral bone loss and periodontal disease. J Periodontol 67(Suppl 10): 1076-1084.
54. Walton-Bowen K, Mantick N (2000). Gaucher Registry Annual Aggregate Data Report.
55. Weigler JM, Seldin R, Minkowitz S (1967). Gaucher's disease involving the mandible: report of case. J Oral Surg 25: 158-163.
56. Weinreb NJ, Charrow J, Andersson HC et al (2002). Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5years of treatment: a report from the Gaucher Registry. Am J Med 113: 112-119.
57. Wenstrup RJ, Roca-Espiau M, Weinreb NJ, Bembi B (2002). Skeletal aspects of Gaucher disease: a review. Br J Radiol 75(Suppl 1): A2-A12.
58. Zimran A (2011). How I treat Gaucher disease. Blood 118: 1463-1471.
59. Zimran A, Elstein D (2010). Lipid storage diseases. In: Lichtman MA, Kipps T, Seligsohn U, Kaushansky K, Prchal JT, eds. Williams hematology. 8th edn. New York: McGraw-Hill, pp. 1065-1070.
60. Zimran A, Abrahamov A, Aker M, Matzner Y (1993). Correction of neutrophil chemotaxis defect in patients with Gaucher disease by low-dose enzyme replacement therapy. Am J Hematol 43: 69-71.
61. Zimran A, Elstein D, Levy-Lahad E et al (1995). Replacement therapy with imiglucerase for type 1 Gaucher's disease. Lancet 345: 1479-1480.